Clinical trial
Efficacy of Valproate in Peripheral Neuropathic Pain
NCT00221637 · University Hospital, Bordeaux, Other · Terminated
Key facts
| NCT number | NCT00221637 |
|---|---|
| Title | Efficacy of Valproate in Peripheral Neuropathic Pain |
| Official title | Efficacy of a Therapeutic Strategy in Peripheral Neuropathic Pain: Intravenous Sodium Valproate Followed by Oral Route Treatment Versus Placebo (Clinical and Neurophysiologic Evaluation) |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Sanofi-Synthelabo Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Neuralgia, Neuropathic Peripheral Pain |
| Intervention type | Drug |
| Interventions | Sodium Valproate |
| Enrollment | 40 |
| Start date | Mar 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 13, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: